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SHORT REPORT
Successful management of intraoperative hemorrhage from placenta
previa accreta: intrauterine tamponade balloons brought out through
the abdominal wall
Eiji Kondoh, Kaoru Kawasaki, Akeo Kawamura, Akihiko Ueda, Kohei Fujita, and Ikuo Konishi
Department of Gynecology and Obstetrics, Kyoto University, Kyoto, Japan
Abstract
Background: Conservative management for placenta previa accreta (PPA) may be preferred, but
uncontrollable hemorrhage sometimes occurs during a cesarean section.
Case: We present a case with a successful maneuver for the management of intraoperative
hemorrhage in PPA. Profuse hemorrhage occurred due to partial placental separation during a
cesarean section. The bleeding was stopped by the placement of intrauterine tamponade
balloons with their shafts passed through the anterior abdominal wall. The catheters were
removed after 24 h. The patient had no complications, and the placenta spontaneously
resorbed three months after delivery.
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Case report
A 33-year-old Japanese woman, gravida 1, para 1, had a
scheduled cesarean section at 36 weeks’ gestation with
diagnosis of placenta previa accreta (PPA) with suspected
bladder invasion. She had a history of cesarean section at 33
weeks’ gestation for fetal growth restriction and preeclampsia.
Under spinal anesthesia, the patient underwent the placement
of ureteral single pigtail stents. The bladder was difficult to
separate from the highly vascular lower uterine segment. A
vertical uterine incision was performed to avoid incising the
placenta, and a 2654 g healthy female infant was delivered
with Apgar scores of 8 and 9 at 1 and 5min, respectively.
Oxytocin administration led to appropriate uterine contrac-
tions, but the majority of the placenta did not separate.
However, significant bleeding occurred from a relatively
small site of the placental detachment immediately after
delivery, and persisted despite hemostatic suturing. Two
100-mL saline-filled 22-Fr Foley balloon catheters were
placed in the uterus, and the hemorrhage stopped. Because the
cervical canal was completely covered with the placenta left
in situ, the distal ends of the balloon shafts were placed
through the cesarean hysterotomy incision and the anterior
abdominal wall (Figure 1A–C). A penrose drain was placed
around the anterior cul-de-sac. Although the patient’s hemo-
globin dropped from 10.0 to 7.1 g/dL, she remained in
hemodynamically stable condition using transfusion of 1600 g
autologous blood and 320 g intraoperative cell salvage. The
catheters were easily removed after 24 h. Intra- and post-
operative antibiotics were performed using intravenous
administration of tazobactam sodiumand piperacillin sodium
for five days. Oral methylergometrine maleate (0.75mg per
day) and metronidazole vaginal suppositories (250mg) were
used for approximately three months. The patient had no
complications, including delayed hemorrhage and infection.
Ultrasonograpy follow-up every 2 weeks showed that the
placenta gradually resorbed spontaneously, and the pla-
centa completely disappeared at 95th day after delivery
(Figure 1D–F).
Discussion
We found that placement of intrauterine tamponade balloons
brought out through the abdominal wall at the time of
cesarean delivery was a useful addition to the options for
management of profuse intraoperative hemorrhage in a
patient with PPA.
PPAwith bladder invasion is associated with a 5.7% risk of
maternal mortality and high morbidity including severe
hemorrhage and urologic injury [1]. The management strat-
egy at cesarean delivery is a cesarean hysterectomy or
conservative management that leaves the placenta in situ.
Conservative management has been gradually accepted
because it can avoid uncontrollable bleeding and severe
injury of the bladder. Sentilhes et al. reported that approxi-
mately 80% of placenta accreta can be conservatively treated
[2], and the placenta often resorbed spontaneously [2,3].
However, partial detachment of the placenta after delivery of
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the baby causes massive hemorrhage and usually prompts
hysterectomy. The cesarean hysterectomy is, however, linked
to further blood loss and urologic complications, especially in
cases with PPA with bladder involvement [1]. Conservative
management, leaving the placenta in situ, is another option to
reduce hemorrhage, to preserve fertility, and to prevent
damage to the bladder or the ureters [2,3]. This can be
attempted for a woman who is not bleeding significantly at
cesarean delivery. If massive hemorrhage is encountered,
emergent transcatheter arterial embolization (TAE) is needed
to keep a chance of conservative treatment [3]. Successful
TAE is almost necessary for conservative management. In our
institution, conservative treatment is routinely performed for
PPA, and multidisciplinary teams, including interventional
radiologists, are assembled in each case as it is difficult to
predict which case presents profuse bleeding. Intraoperative
intractable bleeding otherwise necessitates hysterectomy.
In recent years, intrauterine tamponade balloons have been
widely used for the management of postpartum hemorrhage
[4]. The balloon provides tamponade to the placenta and to
the endometrial surface at the disrupted site of the placenta.
The catheter allows drainage to monitor ongoing blood loss.
Albayrak et al. reported the use of intrauterine balloon
tamponade for PPA [5], and we also experienced two cases of
PPA in which bleeding was successfully controlled by
intrauterine balloon tamponade (unpublished data).
Albayrak et al. stated that the placenta was extirpated in
fragments [5], and our previous two cases had partially
adherent placenta and more than half the placenta detached
spontaneously. Intrauterine tamponade balloons were there-
fore placed with the stem brought out through the vagina.
However, when placenta is abnormally adherent to the
extensive area of myometrium covering internal os, forced
manual removal of the placenta in an attempt to obtain an
empty uterus should be avoided because it causes massive
hemorrhage. To date, intrauterine tamponade balloons have
not been used for the conservative management of PPA with
the placenta completely left in situ because the ends of the
catheters are not passed through the uterine cervix. In this
case, the balloon was placed with the stem brought out not
through the vagina but through the anterior abdominal wall.
Bakri balloon, which just became available this April in
Japan, would obviate the need for two uterine exit wounds. To
the best of our knowledge, we are the first to apply this
technique to control intraoperative hemorrhage of PPA. This
method is feasible, and less invasive and less timeconsuming
than TAE and hysterectomies. It is controversial whether or
not balloon tamponade could be contraindicated in placenta
previa percreta. As the increases of intrauterine pressure by
balloons might cause uterine rupture, further investigation is
needed to clarify the safety of this technique for placenta
previa percreta. We believe that when attempting conservative
management of PPA, intrauterine balloon is a worthwhile
approach for intraopertive hemorrhage, and may save TAE
and improve the success rate of conservative treatment.
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Figure 1. Intrauterine tamponade balloons for placenta previa accreta (A–C) and serial ultrasound images of the placenta (D–F). A scheme (A) shows
that the surface of the balloon is tightly opposed to the disrupted site of the placenta (arrow). The shafts of Foley balloon catheters were brought through
the cesarean hysterotomy incision (B) and through the anterior abdominal wall (C). Transvaginal ultrasonography shows that the placenta left in situ
exists between intrauterine tamponade balloons and internal os (arrowhead) on postoperative day 1 (D). The retained placenta (E, postoperative day 39)
completely disappeared on postoperative day 95 (F).
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